References
1. Huby, T., & Gautier, E. L. (2021). Immune cell-mediated features of
non-alcoholic steatohepatitis. Nature Reviews. Immunology, 1-15.
Advance online publication.
2. Abdelmalek, M. F. (2021). Non-alcoholic fatty liver disease: another
leap forward. Nature reviews. Gastroenterology & hepatology,
18 (2),85-86.
3. Raza, S., Rajak, S., Upadhyay, A., Tewari, A., & Anthony Sinha, R.
(2021). Current treatment paradigms and emerging therapies for
NAFLD/NASH. Frontiers in bioscience (Landmark edition), 26 (2),
206-237.
4. Yoo, J. J., Kim, W., Kim, M. Y., Jun, D. W., Kim, S. G., Yeon, J. E.,
Lee, J. W., Cho, Y. K., Park, S., Sohn, J. H., & the Korean Association
for the Study of the Liver (KASL)-Korea Non-alcoholic fatty liver Study
Group (KNSG) (2019). Recent research trends and updates on non-alcoholic
fatty liver disease. Clinical and molecular hepatology, 25 (1),
1-11.
5. Kang, S. H., Lee, H. W., Yoo, J. J., Cho, Y., Kim, S. U., Lee, T. H.,
Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., Jun, D. W., Choi, J. I.,
Song, D. S., Kim, W., Jeong, S. W., Kim, M. Y., Koh, H., Jeong, S., Lee,
J. W., Cho, Y. K.,… Korean Association for the Study of the Liver
(KASL) (2021). KASL clinical practice guidelines: Management of
non-alcoholic fatty liver disease. Clinical and molecular
hepatology, 27 (3), 363-401.
6. Lee, H. L., Lee, J., Cha, J. H., Cho, S., Sung, P. S., Hur, W., Yoon,
S. K., & Bae, S. H. (2022). Anti-fibrotic effects of branched-chain
amino acids on hepatic stellate cells. The Korean journal of
internal medicine, 37 (1), 53-62.
7. Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao,
X. Y., Ji, Y., Li, C., Guo, L., Zhou, L., Chen, Z., Leon-Mimila, P.,
Chung, M. T., Kurabayashi, K., Opp, J., Campos-Perez, F.,
Villamil-Ramirez, H., Canizales-Quinteros, S., Lyons, R.,…Lin, J.
D. (2019). Landscape of Intercellular Crosstalk in Healthy and NASH
Liver Revealed by Single-Cell Secretome Gene Analysis. Molecular
cell, 75 (3), 644-660.e5.
8. Seidman, J. S., Troutman, T. D., Sakai, M., Gola, A., Spann, N. J.,
Bennett, H., Bruni, C. M., Ouyang, Z., Li, R. Z., Sun, X., Vu, B. T.,
Pasillas, M. P., Ego, K. M., Gosselin, D., Link, V. M., Chong, L. W.,
Evans, R. M., Thompson, B. M., McDonald, J. G., Hosseini,
M.,…Glass, C. K. (2020). Niche-Specific Reprogramming of
Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic
Steatohepatitis. Immunity, 52 (6), 1057-1074.e7.
9. Remmerie, A., Martens, L., Thone, T., Castoldi, A., Seurinck, R.,
Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M.,
Binte Abdul Latib, M., Devisscher, L., Hoorens, A., Bonnardel, J.,
Vandemme, N., Kremer, A., Borghgraef, P., Van Vlierberghe, H., Lippens,
S., Pearce, E.,…Scott, C. L. (2020). Osteopontin Expression
Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells
in the Fatty Liver. Immunity, 53 (3), 641-657e14.
10. Tran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gelineau,
A., Marcelin, G., Magreau-Davy, E., Ouhachi, M., Lesnik, P., Boissonnas,
A., Le Goff, W., Clausen, B. E., Yvan-Charvet, L., Sennlaub, F., Huby,
T., & Gautier, E. L. (2020). Impaired Kupffer Cell Self-Renewal Alters
the Liver Response to Lipid Overload during Non-alcoholic
Steatohepatitis. Immunity, 53 (3), 627-640.e5.
11. Krenkel, O., Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J.
C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand,
C., Weiskirchen, R., Longerich, T., Costa, I. G., Anstee, Q. M.,
Trautwein, C., & Tacke, F. (2018). Therapeutic inhibition of
inflammatory monocyte recruitment reduces steatohepatitis and liver
fibrosis. Hepatology (Baltimore, Md.), 67 (2), 1270-1283.
12. Sung, P. S. Crosstalk between tumour-associated macrophages and
neighboring cells in hepatocellular carcinoma. Clinical and
molecular hepatology. Advance online publication.
13. Sung, P. S., Kim, C. M., Cha, J. H., Park, J. Y., Yu, Y. S., Wang,
H. J., Kim, J. K., & Bae, S. H. (2022). A Unique Immune-Related Gene
Signature Represents Advanced Liver Fibrosis and Reveals Potential
Therapeutic Targets. Biomedicines, 10 (1), 180.
14. Krenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M.,
Puengel, T., Roth, T., Branco, D., Mossanen, J. C., Luedde, T.,
Trautwein, C., Costa, I. G., & Tacke, F. (2020). Myeloid cells in liver
and bone marrow acquire a functionally distinct inflammatory phenotype
during obesity-related steatohepatitis. Gut, 69 (3), 551-563.
15. Lee, S. W., Kim, S. M., Hur, W., Kang, B. Y., Lee, H. L., Nam, H.,
Yoo, S. H., Sung, P. S., Kwon, J. H., Jang, J. W., Kim, S. J., & Yoon,
S. K. (2021). Tenofovir disoproxil fumarate directly ameliorates liver
fibrosis by inducing hepatic stellate cell apoptosis via downregulation
of PI3K/Akt/mTOR signalling pathway. PLoS One, 16 (12), e0261067.
16. Zhao, J., Han, M., Zhou, L., Liang, P., Wang, Y., Feng, S., Lu, H.,
Yuan, X., Han, K., Chen, X., Liu, S., & Cheng, J. (2020). TAF and TDF
attenuate liver fibrosis through NS5ATP9, TGFbeta1/Smad3, and
NF-kappaB/NLRP3 inflammasome signalling pathways. Hepatology
international, 14 (1), 145-160.
17. Park, D. J., Sung, P. S., Kim, J. H., Lee, G. W., Jang, J. W., Jung,
E. S., Bae, S. H., Choi, J. Y., & Yoon, S. K. (2020). EpCAM-high liver
cancer stem cells resist natural killer cell-mediated cytotoxicity by
upregulating CEACAM1. Journal for immunotherapy of cancer, 8 (1),
e000301.
18. Sung, P. S., Park, D. J., Roh, P. R., Do Mun, K., Cho, S. W., Lee,
G. W., Jung, E. S., Lee, S. H., Jang, J. W., Bae, S. H., Choi, J. Y.,
Choi, J., Ahn, J., & Yoon, S. K. (2022). Intrahepatic inflammatory IgA+
PD-L1-high monocytes in hepatocellular carcinoma development and
immunotherapy. Journal for immunotherapy of cancer, 10 (5),
e003618.
19. Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F.,
Henderson, B. E. P., Luu, N. T. Portman, J. R., Matchett, K. P., Brice,
M., Marwick, J. A., Taylor, R. S., Efremova, M., Vento-Tormo, R.,
Carragher, N. O., Kendall, T. J., Fallowfield, J. A., Harrison, E. M.,
Mole, D. J., Wigmore, S. J., Newsome, P. N., … Henderson, N. C.
(2019). Resolving the fibrotic niche of human liver cirrhosis at
single-cell level. Nature, 575 (7783), 512-518.
20. Saito, K., Uebanso, T., Maekawa, K., Ishikawa, M., Taguchi, R.,
Nammo, T., Nishimaki-Mogami, T., Udagawa, H., Fujii, M., Shibazaki, Y.,
Yoneyama, H., Yasuda, K., & Saito, Y. (2015). Characterization of
hepatic lipid profiles in a mouse model with nonalcoholic
steatohepatitis and subsequent fibrosis. Scientific reports, 5,12466.
21. Carpino, G., Del Ben, M., Pastori, D., Carnevale, R., Baratta, F.,
Overi, D., Francis, H., Cardinale, V., Onori, P., Safarikia, S.,
Cammisotto, V., Alvaro, D., Svegliati-Baroni, G., Angelico, F., Gaudio,
E., & Violi, F. (2020). Increased Liver Localization of
Lipopolysaccharides in Human and Experimental NAFLD. Hepatology
(Baltimore, Md.), 72 (2), 470-485.
22. Sripongpun, P., Kim, W. R., Mannalithara, A., Kwong, A., Daugherty,
T., Goel, A., & Kwo, P. Y. (2022). Tenofovir Alafenamide Attenuates
Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase
Activities in Patients With Chronic Hepatitis B. Clinical
gastroenterology and hepatology: the official clinical practice journal
of the American Gastroenterological Association, 20 (1), 230-2.
23. Linton, M. F., Moslehi, J. J., & Babaev, V. R. (2019). Akt
Signalling in Macrophage Polarization, Survival, and Atherosclerosis.International journal of molecular sciences, 20 (11), 2703.
24. Lopez-Pelaez, M., Soria-Castro, I., Bosca, L., Fernandez, M., &
Alemany, S. (2011). Cot/tpl2 activity is required for TLR-induced
activation of the Akt p70 S6k pathway in macrophages: Implications for
NO synthase 2 expression. European journal of immunology, 41 (6),
1733-1741.
25. Lee, S. J., Seo, K. W., & Kim, C. D. (2015). LPS Increases 5-LO
Expression on Monocytes via an Activation of Akt-Sp1/NF-kappaB Pathways.The Korean journal of physiology & pharmacology: official journal
of the Korean Physiological Society and the Korean Society of
Pharmacology, 19 (3), 263-268.